Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01294787
Show Display Options
Rank Status Study
1 Completed
Has Results
Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Condition: COPD
Interventions: Drug: indacaterol and glycopyrronium bromide (QVA149);   Drug: placebo;   Drug: tiotropium

Indicates status has not been verified in more than two years